India’s Stempeutics Cleared To Test Nation’s Stem Cell-Based Drugs
This article was originally published in PharmAsia News
Executive Summary
India's drug regulators have cleared another company to conduct clinical trials, this one specializing on use of drugs that are based on stem cells for treating heart problems. The Drug Controller General Of India approved Stempeutics Research to become the nation's first firm to conduct trials of stem cell-based drugs. Stempeutics plans to focus on adult stem cells in mesenchymal derived from bone marrow as it invests heavily in attempting to develop new products. (Click here for more